-
1
-
-
67650451498
-
Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration
-
A.S. Levey, D. Cattran, and A. Friedman Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration Am J Kidney Dis 54 2 2009 205 226
-
(2009)
Am J Kidney Dis
, vol.54
, Issue.2
, pp. 205-226
-
-
Levey, A.S.1
Cattran, D.2
Friedman, A.3
-
2
-
-
84903276794
-
Early change in proteinuria as a surrogate end point for kidney disease progression: An individual patient meta-analysis
-
L.A. Inker, A.S. Levey, K. Pandya, N. Stoycheff, A. Okparavero, and T. Greene Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis Am J Kidney Dis 64 1 2014 74 85
-
(2014)
Am J Kidney Dis
, vol.64
, Issue.1
, pp. 74-85
-
-
Inker, L.A.1
Levey, A.S.2
Pandya, K.3
Stoycheff, N.4
Okparavero, A.5
Greene, T.6
-
3
-
-
84902826499
-
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality
-
J. Coresh, T.C. Turin, and K. Matsushita Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality JAMA 311 24 2014 2518 2531
-
(2014)
JAMA
, vol.311
, Issue.24
, pp. 2518-2531
-
-
Coresh, J.1
Turin, T.C.2
Matsushita, K.3
-
4
-
-
84892925764
-
Estimated GFR decline as a surrogate end point for kidney failure: A post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes with the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial
-
H.J. Lambers Heerspink, M. Weldegiorgis, and L.A. Inker Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial Am J Kidney Dis 63 2 2014 244 250
-
(2014)
Am J Kidney Dis
, vol.63
, Issue.2
, pp. 244-250
-
-
Lambers Heerspink, H.J.1
Weldegiorgis, M.2
Inker, L.A.3
-
5
-
-
34249702586
-
Surrogate end points for clinical trials of kidney disease progression
-
L.A. Stevens, T. Greene, and A.S. Levey Surrogate end points for clinical trials of kidney disease progression Clin J Am Soc Nephrol 1 4 2006 874 884
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, Issue.4
, pp. 874-884
-
-
Stevens, L.A.1
Greene, T.2
Levey, A.S.3
-
6
-
-
0024520844
-
Surrogate endpoints in clinical trials: Definition and operational criteria
-
R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 4 1989 431 440
-
(1989)
Stat Med
, vol.8
, Issue.4
, pp. 431-440
-
-
Prentice, R.L.1
-
7
-
-
0033603794
-
Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group
-
H.C. Bucher, G.H. Guyatt, D.J. Cook, A. Holbrook, and F.A. McAlister Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group JAMA 282 8 1999 771 778
-
(1999)
JAMA
, vol.282
, Issue.8
, pp. 771-778
-
-
Bucher, H.C.1
Guyatt, G.H.2
Cook, D.J.3
Holbrook, A.4
McAlister, F.A.5
-
8
-
-
72049128645
-
Change in estimated GFR associates with coronary heart disease and mortality
-
K. Matsushita, E. Selvin, L.D. Bash, N. Franceschini, B.C. Astor, and J. Coresh Change in estimated GFR associates with coronary heart disease and mortality J Am Soc Nephrol 20 12 2009 2617 2624
-
(2009)
J Am Soc Nephrol
, vol.20
, Issue.12
, pp. 2617-2624
-
-
Matsushita, K.1
Selvin, E.2
Bash, L.D.3
Franceschini, N.4
Astor, B.C.5
Coresh, J.6
-
9
-
-
72049117391
-
Rapid decline of kidney function increases cardiovascular risk in the elderly
-
M.G. Shlipak, R. Katz, and B. Kestenbaum Rapid decline of kidney function increases cardiovascular risk in the elderly J Am Soc Nephrol 20 12 2009 2625 2630
-
(2009)
J Am Soc Nephrol
, vol.20
, Issue.12
, pp. 2625-2630
-
-
Shlipak, M.G.1
Katz, R.2
Kestenbaum, B.3
-
10
-
-
84868556470
-
Short-term change in kidney function and risk of end-stage renal disease
-
T.C. Turin, J. Coresh, and M. Tonelli Short-term change in kidney function and risk of end-stage renal disease Nephrol Dial Transplant 27 10 2012 3835 3843
-
(2012)
Nephrol Dial Transplant
, vol.27
, Issue.10
, pp. 3835-3843
-
-
Turin, T.C.1
Coresh, J.2
Tonelli, M.3
-
11
-
-
84862173307
-
One-year change in kidney function is associated with an increased mortality risk
-
T.C. Turin, J. Coresh, and M. Tonelli One-year change in kidney function is associated with an increased mortality risk Am J Nephrol 36 1 2012 41 49
-
(2012)
Am J Nephrol
, vol.36
, Issue.1
, pp. 41-49
-
-
Turin, T.C.1
Coresh, J.2
Tonelli, M.3
-
12
-
-
84875709047
-
Change in the estimated glomerular filtration rate over time and risk of all-cause mortality
-
T.C. Turin, J. Coresh, and M. Tonelli Change in the estimated glomerular filtration rate over time and risk of all-cause mortality Kidney Int 83 4 2013 684 691
-
(2013)
Kidney Int
, vol.83
, Issue.4
, pp. 684-691
-
-
Turin, T.C.1
Coresh, J.2
Tonelli, M.3
-
13
-
-
55949102694
-
Rapid kidney function decline and mortality risk in older adults
-
D.E. Rifkin, M.G. Shlipak, and R. Katz Rapid kidney function decline and mortality risk in older adults Arch Intern Med 168 20 2008 2212 2218
-
(2008)
Arch Intern Med
, vol.168
, Issue.20
, pp. 2212-2218
-
-
Rifkin, D.E.1
Shlipak, M.G.2
Katz, R.3
-
14
-
-
80051569374
-
GFR decline and mortality risk among patients with chronic kidney disease
-
R.M. Perkins, I.D. Bucaloiu, H.L. Kirchner, N. Ashouian, J.E. Hartle, and T. Yahya GFR decline and mortality risk among patients with chronic kidney disease Clin J Am Soc Nephrol 6 8 2011 1879 1886
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.8
, pp. 1879-1886
-
-
Perkins, R.M.1
Bucaloiu, I.D.2
Kirchner, H.L.3
Ashouian, N.4
Hartle, J.E.5
Yahya, T.6
-
15
-
-
78149302507
-
Rate of kidney function decline associates with mortality
-
Z. Al-Aly, A. Zeringue, and J. Fu Rate of kidney function decline associates with mortality J Am Soc Nephrol 21 11 2010 1961 1969
-
(2010)
J Am Soc Nephrol
, vol.21
, Issue.11
, pp. 1961-1969
-
-
Al-Aly, Z.1
Zeringue, A.2
Fu, J.3
-
16
-
-
84869223202
-
Greater variability in kidney function is associated with an increased risk of death
-
Z. Al-Aly, S. Balasubramanian, J.R. McDonald, J.F. Scherrer, and A.M. O'Hare Greater variability in kidney function is associated with an increased risk of death Kidney Int 82 11 2012 1208 1214
-
(2012)
Kidney Int
, vol.82
, Issue.11
, pp. 1208-1214
-
-
Al-Aly, Z.1
Balasubramanian, S.2
McDonald, J.R.3
Scherrer, J.F.4
O'Hare, A.M.5
-
17
-
-
84865202588
-
The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease
-
J. Skupien, J.H. Warram, and A.M. Smiles The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease Kidney Int 82 5 2012 589 597
-
(2012)
Kidney Int
, vol.82
, Issue.5
, pp. 589-597
-
-
Skupien, J.1
Warram, J.H.2
Smiles, A.M.3
-
19
-
-
84902838153
-
GFR decline as an endpoint for clinical trials in CKD
-
[abstract]
-
L. Inker, H.J. Lambers Heerspink, H. Mondal, J. Coresh, T. Greene, and A.S. Levey GFR decline as an endpoint for clinical trials in CKD [abstract] J Am Soc Nephrol 24 2013 12A
-
(2013)
J Am Soc Nephrol
, vol.24
, pp. 12A
-
-
Inker, L.1
Lambers Heerspink, H.J.2
Mondal, H.3
Coresh, J.4
Greene, T.5
Levey, A.S.6
-
20
-
-
84902785403
-
Validity and statistical power of alternative eGFR-based endpoints: A report from an NFK FDA Workshop
-
[abstract]
-
T.H. Greene, C.-C. Teng, and A.M. Redd Validity and statistical power of alternative eGFR-based endpoints: a report from an NFK FDA Workshop [abstract] J Am Soc Nephrol 24 2013 151A
-
(2013)
J Am Soc Nephrol
, vol.24
, pp. 151A
-
-
Greene, T.H.1
Teng, C.-C.2
Redd, A.M.3
-
21
-
-
84862777509
-
Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis
-
A.M. O'Hare, A. Batten, and N.R. Burrows Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis Am J Kidney Dis 59 4 2012 513 522
-
(2012)
Am J Kidney Dis
, vol.59
, Issue.4
, pp. 513-522
-
-
O'Hare, A.M.1
Batten, A.2
Burrows, N.R.3
-
22
-
-
84864397514
-
CKD progression: A risky business
-
A. Chang, and H. Kramer CKD progression: a risky business Nephrol Dial Transplant 27 7 2012 2607 2609
-
(2012)
Nephrol Dial Transplant
, vol.27
, Issue.7
, pp. 2607-2609
-
-
Chang, A.1
Kramer, H.2
-
23
-
-
84859879072
-
Improvement in kidney function: A real occurrence
-
T.C. Turin, and B.R. Hemmelgarn Improvement in kidney function: a real occurrence J Am Soc Nephrol 23 4 2012 575 577
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.4
, pp. 575-577
-
-
Turin, T.C.1
Hemmelgarn, B.R.2
-
24
-
-
84870602492
-
Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease
-
R.M. Perkins, X. Tang, A.C. Bengier, H.L. Kirchner, and I.D. Bucaloiu Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease Kidney Int 82 12 2012 1332 1338
-
(2012)
Kidney Int
, vol.82
, Issue.12
, pp. 1332-1338
-
-
Perkins, R.M.1
Tang, X.2
Bengier, A.C.3
Kirchner, H.L.4
Bucaloiu, I.D.5
-
25
-
-
84859808611
-
Kidney function can improve in patients with hypertensive CKD
-
B. Hu, C. Gadegbeku, and M.S. Lipkowitz Kidney function can improve in patients with hypertensive CKD J Am Soc Nephrol 23 4 2012 706 713
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.4
, pp. 706-713
-
-
Hu, B.1
Gadegbeku, C.2
Lipkowitz, M.S.3
-
26
-
-
76749156220
-
Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort
-
B.O. Eriksen, J. Tomtum, and O.C. Ingebretsen Predictors of declining glomerular filtration rate in a population-based chronic kidney disease cohort Nephron Clin Pract 115 1 2010 c41 c50
-
(2010)
Nephron Clin Pract
, vol.115
, Issue.1
, pp. 41-c50
-
-
Eriksen, B.O.1
Tomtum, J.2
Ingebretsen, O.C.3
-
27
-
-
0026011647
-
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial
-
D.S. Echt, P.R. Liebson, and L.B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 12 1991 781 788
-
(1991)
N Engl J Med
, vol.324
, Issue.12
, pp. 781-788
-
-
Echt, D.S.1
Liebson, P.R.2
Mitchell, L.B.3
|